Cholangiocarcinoma (CCA) includes a cluster of highly heterogeneous biliary malignant
tumours that can arise at any point of the biliary tree. Their incidence is increasing globally …

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due
to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular …

Cholangiocarcinoma (CCA) is a heterogeneous disease arising from a complex interaction
between host‐specific genetic background and multiple risk factors. Globally, CCA …

This review is an abbreviated version of a report prepared for the American Cancer Society
Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt …

Background & Aims Cholangiocarcinoma (CCA) carries a poor prognosis, is increasing in
incidence and its causes are poorly understood. Although some risk factors are known, they …

There are limited published data on recent cancer incidence and mortality trends worldwide.
We used the International Agency for Research on Cancer's CANCER Mondial …

Cancer constitutes an enormous burden on society in more and less economically
developed countries alike. The occurrence of cancer is increasing because of the growth …

Liver cancer is the second leading cause of cancer mortality worldwide, causing more than
700,000 deaths annually. Because of the wide landscape of genomic alterations and limited …

Gallbladder cancer (GBC) is rare, but is the most malignant type of biliary tract tumor.
Unfortunately, only a small population of cancer patients is acceptable for the surgical …

The global burden of cancer continues to increase largely because of the aging and growth
of the world population alongside an increasing adoption of cancer‐causing behaviors …